A recent study indicates that people who stop using blockbuster weight-loss injections like Mounjaro or Wegovy may regain shed pounds much more quickly than those who stop conventional lifestyle regimens.
Findings released in a leading health publication demonstrates that while obese people frequently drop a large proportion of their total mass while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.
"People using such treatments should be aware of the potential of quick weight regain when the treatment concludes," cautioned researcher Dr. Susan Jebb.
This pace of regain suggests a reversion to original mass within about a year and a half.
Comparing Therapies
The analysis, which examined dozens of trials involving over 9,000 of patients, contrasted the effects of the injectable medications with older methods.
The team note that people who lose weight through lifestyle changes alone usually see a more gradual creep back—around 100 grams monthly—after stopping.
Explaining the Quick Rebound
Nutrition scientists believe the way of the drugs explains the amplified weight return.
GLP-1 drugs copy a natural hormone called GLP-1, which controls hunger.
"Long-term administration of the hormone concentrations far above than the body's typical production could lead to the body to produce less of its own natural hormone, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication leads to appetite is uncontrolled, making binge eating far more likely."
A Lifelong Disease?
The NHS advise the injections for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, due to the high risk of weight regain, the treatment might need to be ongoing.
This perspective is echoed by drug manufacturers, who note that the findings "emphasize the persistent character of excess weight," comparing it to managing conditions like diabetes.
User Testimonies
Users who have come off the medication describe a intense resurgence of hunger.
"It felt as if something that goes on and you become starving," recalled an individual.
The struggle is compounded if users have not established permanent dietary or behavioural modifications during therapy.
Widespread Interest
Survey data indicate that millions of adults in the UK have used these injections in the past year, with interest continuing to grow.
- Use is more common among women compared to men.
- The 40s and 50s age group shows the highest level of interest.
- A large proportion access the medications through private prescriptions rather than public health services.
In conclusion, clinicians stress that while these medications are effective tools for shedding pounds, they are not a permanent solution and long-term success relies on combined lifestyle management.
